In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Pfizer (PFE – Research Report), with a price target ...

Shares of Iovance Biotherapeutics have plummeted post-Amtagvi approval. Read more to see a full investment analysis for IOVA ...